Clinical Study of CLL1 CAR-T Cells in the Treatment of Hematological Malignancies
Clinical trial NCT05252572 · UNKNOWN
Trial details
- NCT number
- NCT05252572
- Sponsor
- Zhejiang University
- Status
- UNKNOWN
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-28
- Primary completion
- 2024-11-30
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.